GlioCure
Created in 2016
Up & running (A)
Existing signals show a regular activitySocial networks
151 2,250 2,005Activities
Technologies
Entity types
Location
Institut de Biologie en Santé, Rue des Capucins, 49100 Angers, France
Angers
France
Employees
Scale: 2-10
Estimated: 5
SIREN
822444840Engaged catalyst
12
0 0Added in Motherbase
6 years, 7 months ago
Value proposition
A preclinical-stage drug-development company specialized in neuro-oncology
GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year.
To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs.
GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights.
GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan:
Louis-Marie is a biotech entrepreneur with 15 years of experience in the field of innovative therapies and rare diseases;
Claire, specialist of the neuronal cytoskeleton, has sound knowledge of preclinical experimental techniques;
Its Scientific & Medical Advisory Board is composed of leading international experts in research and treatment of glioblastoma.
Glioblastoma, Glioma, Neurooncology, Innovative therapies, Nanomedicines, Rare diseases, Neurosurgery, Brain tumors, Orphan drugs, and PeptideOriginal language
A preclinical-stage drug-development company specialized in neuro-oncology
GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year.
To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs.
GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights.
GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan:
Louis-Marie is a biotech entrepreneur with 15 years of experience in the field of innovative therapies and rare diseases;
Claire, specialist of the neuronal cytoskeleton, has sound knowledge of preclinical experimental techniques;
Its Scientific & Medical Advisory Board is composed of leading international experts in research and treatment of glioblastoma.
Gliocure : Gliocure
https://www.gliocure.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 4 Feb 2024 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 20 Feb 2018 2 Apr 2025 | | |
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Not capitalistic Partnership Event 6 Feb 2019 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Not capitalistic Partnership Event 7 Feb 2018 | | |
 Région Pays de la Loire National and local authorities, Government Administration | Région Pays de la Loire National and local authorities, Government Administration | Other 30 Jan 2020 31 May 2022 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 5 Nov 2019 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Not capitalistic Partnership Not event 19 Nov 2020 | | |
 CCO Nantes Events Services | CCO Nantes Events Services | Not capitalistic Partnership Event 28 Jun 2018 | | |
 Angers Technopole Business Consulting and Services | Angers Technopole Business Consulting and Services | Not capitalistic Not partnership Event 22 Sep 2020 26 Feb 2025 | | |
 SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Not capitalistic Not partnership Event 15 Jun 2017 | | |